Carter's (CRI) Tops Q1 EPS by 15c

Carter's (NYSE: CRI) reported Q1 EPS of $0.87, $0.15 better than the analyst estimate of $0.72. Revenue for the quarter came in at $741 million versus the consensus estimate of $724.05 million.

• Company reaffirms full year fiscal 2019 outlook: net sales growth of 1% to 2%; adjusted diluted EPS growth of 4% to 6%

For earnings history and earnings-related data on Carter's (CRI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c